We are a precision medicine pioneer in psychiatry based in Munich. Founded in 2010, our privately held biotech company combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression.
Our ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. We strives to reduce not only the immense individual burden, but also the societal impact of these diseases.
We develop patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.
Location: Germany, Bavaria, Munich
Member count: 11-50
Total raised: $24.779938M
Founded date: 2010
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 25.10.2022 | - | $14.097433... | - | vcbay.news... |
| 03.08.2021 | - | $10.682505... | - | - |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 25.10.2022 | HMNC Brain... | HMNC Brain Health, a clinical ... | - | - | bio-m.org/... |
| 22.10.2022 | Germany-ba... | Munich, Germany-based clinical... | - | - | vcbay.news... |
| 21.10.2022 | HMNC Brain... | HMNC Brain Health, a Munich, G... | Germany | - | finsmes.co... |